Waikato Hospital is a major regional hospital in Hamilton, New Zealand. It provides specialised and emergency healthcare for the Midlands and Waikato area with patients referred there from feeder hospitals like Whakatāne, Lakes area, Tauranga, Thames, Tokoroa and Rotorua.

There are 673 beds in Waikato Hospital.

During the past decade, Waikato Hospital conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 63 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 38 clinical trials were completed. i.e. 105.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Waikato Hospital" #1 sponsor was "Pfizer" with 8 trials, followed by "Shire" with 8 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Trans Tasman Radiation Oncology Group" with 7 trials sponsored and "Galapagos NV" with 7 trials sponsored. Other sponsors include 137 different institutions and companies that sponsored additional 98 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Waikato Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 4 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator and "Gilead Sciences" with 4 trials as a collaborator. Other collaborators include 186 different institutions and companies that were collaborators in the rest 164 trials.

According to Clinical.Site data, the most researched conditions in "Waikato Hospital" are "Ulcerative Colitis" (14 trials), "Crohn's Disease" (9 trials), "Breast Cancer" (7 trials), "Coronary Artery Disease" (7 trials) and "Aortic Valve Stenosis" (6 trials). Many other conditions were trialed in "Waikato Hospital" in a lesser frequency.

Most popular intervention types in "Waikato Hospital" are "Drug" (128 trials), "Other" (27 trials), "Device" (21 trials), "Biological" (16 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Filgotinib" (5 trials), "Etrolizumab" (4 trials), "Ontamalimab" (4 trials) and "Placebo Oral Tablet" (4 trials). Other intervention names were less common.

The vast majority of trials in "Waikato Hospital" are 162 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Waikato Hospital". undefined are not yet recruiting, 23 are recruiting, 39 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 90 completed trials in Waikato Hospital, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Waikato Hospital, 8 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 33 trials that are defined as “Not Applicable".